80%Confidence
0Views
FDASource
2026-03-06Date
Summary
Pro Numb Tattoo Numbing Spray faces cGMP deviations, indicating potential regulatory non-compliance in manufacturing practices. This could lead to market withdrawal and loss of consumer trust in OTC topical anesthetic products.
Actionable: Evaluate alternative numbing product suppliers and monitor FDA enforcement actions.
AI Confidence: 80%
Data Points
firmPro Numb Tattoo Numbing Spray LLC
classificationClass II
statusOngoing
distributionNationwide in the USA
productPro Numb Tattoo Numbing Spray, 5% Lidocaine, [1 FL OZ/28.4 ML or 4 oz/120 mL] per bottle, Distributed by: Pro Numb Tattoo numbing spray LLC, Melbourne
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now